# Hospital Influenza Outbreak Management in the Post-COVID Era: A Narrative Review of Evolving Practices and Feasibility Considerations

**Authors:** Wei-Hsuan Huang, Yi-Fang Ho, Jheng-Yi Yeh, Po-Yu Liu, Po-Hsiu Huang

PMC · DOI: 10.3390/healthcare14010050 · Healthcare · 2025-12-24

## TL;DR

This paper reviews how hospitals can use post-COVID practices like N95 masks and PCR testing to better manage influenza outbreaks and protect patients.

## Contribution

The paper synthesizes post-COVID practices into a standardized, clinician-led approach for hospital influenza outbreak management.

## Key findings

- Layered measures like N95 use and PCR testing reduce hospital influenza transmission.
- Early oseltamivir treatment and vaccination efforts improve patient outcomes and reduce transmission.
- Standardized outbreak playbooks help hospitals respond faster and preserve workforce capacity.

## Abstract

What are the main findings?
Hospital influenza outbreak control has shifted significantly post-COVID, with layered measures (N95 use, ventilation, multiplex PCR) now standard, reducing nosocomial transmission.Quantitative figures and tables (predictive values of diagnostic tests, outbreak thresholds, and intervention schematics) provide evidence-based visuals for clinicians and infection-control teams

Hospital influenza outbreak control has shifted significantly post-COVID, with layered measures (N95 use, ventilation, multiplex PCR) now standard, reducing nosocomial transmission.

Quantitative figures and tables (predictive values of diagnostic tests, outbreak thresholds, and intervention schematics) provide evidence-based visuals for clinicians and infection-control teams

What are the implication of the main findings?
Visual, data-driven tools enable faster recognition and standardized response to influenza outbreaks, helping frontline teams translate guidelines into action.Hospitals can adapt COVID-era practices into routine seasonal influenza playbooks, preserving workforce capacity and protecting vulnerable patients.

Visual, data-driven tools enable faster recognition and standardized response to influenza outbreaks, helping frontline teams translate guidelines into action.

Hospitals can adapt COVID-era practices into routine seasonal influenza playbooks, preserving workforce capacity and protecting vulnerable patients.

Background: Hospital-acquired influenza remains a persistent threat that amplifies morbidity, mortality, length of stay, and operational strain, particularly among older and immunocompromised inpatients. The COVID-19 era reshaped control norms—normalizing N95 use during surges, ventilation improvements, and routine multiplex PCR—creating an opportunity to strengthen hospital outbreak management. Methods: We conducted a targeted narrative review of WHO/CDC/Infectious Diseases Society of America (IDSA) guidance and peer-reviewed studies (January 2015–August 2025), emphasizing adult inpatient care. This narrative review synthesizes recent evidence and discusses theoretical implications for practice, rather than establishing formal guidelines. Evidence was synthesized into pragmatic practice statements on detection, diagnostics, isolation/cohorting, antivirals, chemoprophylaxis, vaccination, surveillance, and communication. Results: Early recognition and test-based confirmation are pivotal. For inpatients, nucleic-acid amplification tests are preferred; negative antigen tests warrant PCR confirmation, and lower-respiratory specimens improve yield in severe disease. A practical outbreak threshold is ≥2 epidemiologically linked, laboratory-confirmed cases within 72 h on the same ward. Effective control may require immediate isolation or cohorting with dedicated staff, strict droplet/respiratory protection, and daily active surveillance. Early oseltamivir (≤48 h from onset or on admission) reduces mortality and length of stay; short-course post-exposure prophylaxis for exposed patients or staff lowers secondary attack rates. Integrated vaccination efforts for healthcare personnel and high-risk patients reinforce workforce resilience and reduce transmission. Conclusions: A standardized, clinician-led bundle—early molecular testing, do-not-delay antivirals, decisive cohorting and Personal protective equipment (PPE), targeted chemoprophylaxis, vaccination, and disciplined communication— could help curb transmission, protect vulnerable patients and staff, and preserve capacity. Hospitals should codify COVID-era layered controls for seasonal influenza and rehearse unit-level outbreak playbooks to accelerate response and recovery. These recommendations target clinicians and infection-prevention leaders in acute-care hospitals.

## Linked entities

- **Chemicals:** oseltamivir (PubChem CID 65028)
- **Diseases:** influenza (MONDO:0005812), COVID-19 (MONDO:0100096)

## Full-text entities

- **Diseases:** COVID (MESH:D000086382), infection (MESH:D007239), Infectious Diseases (MESH:D003141), Influenza (MESH:D007251), Post-COVID (MESH:D000094024)
- **Chemicals:** N95 (-), oseltamivir (MESH:D053139)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12786250/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12786250/full.md

## References

78 references — full list in the complete paper: https://tomesphere.com/paper/PMC12786250/full.md

---
Source: https://tomesphere.com/paper/PMC12786250